Location History:
- Snyder, NY (US) (2011)
- East Amherst, NY (US) (2016)
- Buffalo, NY (US) (2019 - 2021)
Company Filing History:
3 out of 3 
2 out of 310 
1 out of 1,997 
Years Active: 2011-2025
Title: Innovations in Cancer Treatment by Inventor Xiang Ling
Introduction
Xiang Ling is a notable inventor based in Buffalo, NY (US), recognized for his significant contributions to cancer treatment through innovative drug formulations. With a total of 6 patents, his work focuses on developing personalized precision medicine aimed at combating various forms of cancer.
Latest Patents
Xiang Ling's latest patents include groundbreaking formulations of the anticancer drug FL118. One patent describes novel formulations of FL118 designed to preclude, eliminate, or reverse cancer phenotypes and treatment resistance. Another patent details the chemical synthesis and application of FL118 platform-derived analogues for treating human diseases. These compounds, derived from chemical modifications of the FL118 platform, can be used alone or in combination with other anti-cancer agents to effectively target multiple cellular proteins and their signaling pathways.
Career Highlights
Throughout his career, Xiang Ling has worked with various organizations, including Canget Biotek Pharma LLC and Health Research, Inc. His innovative approach to drug formulation has positioned him as a key figure in the field of cancer research.
Collaborations
Xiang Ling has collaborated with notable colleagues, including Fengzhi Li and David G Hangauer, contributing to the advancement of cancer treatment methodologies.
Conclusion
Xiang Ling's innovative work in cancer treatment through the development of FL118 formulations exemplifies the potential of personalized medicine in addressing complex health challenges. His contributions continue to pave the way for future advancements in cancer therapies.